Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Edwards Lifesciences Corporation Common Stock (EW) vs McDonald's Corp (MCD) Price & Performance

Edwards Lifesciences Corporation Common StockTrade
McDonald's CorpTrade

Price performance (Past 24H)

Key statistics

Edwards Lifesciences Corporation Common Stock vs McDonald's Corp — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while McDonald's Corp trades at $235.7 (market cap $163.38B). The key difference: McDonald's Corp is far larger — about 3.3× Edwards Lifesciences Corporation Common Stock's market cap, and McDonald's Corp pays a 3.34% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.

EWMCD
Market Cap
$49.44B$163.38B
Volume
3,508,0274,647,229
Sector
HealthConsumer Cyclical
52-Week High
$95.18$341.06
52-Week Low
$72.65$230.88
Enterprise Value
$45.90B$217.15B
Typical Hold Time
—164 Days
Dividend Yield
—3.34%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Edwards Lifesciences Corporation Common Stock

No Aura AI signal available yet.

McDonald's Corp

McDonald's (MCD) trades at $236.9, up 1.91% for the day, with a bearish technical signal despite recent earnings beats. The company reported strong fundamentals with 2025 revenue of $26.89B and net income of $8.56B, supported by a 57.38% gross margin. Recent news highlights a new 'NEXT' growth strategy focusing on automation and menu innovation to counter competitive pressures.

The outlook is mixed: analyst consensus is bullish with a $286.95 price target, but technical indicators and macroeconomic headwinds pose risks. Investment opportunity lies in McDonald's resilient franchise model and dividend yield, though inflation and execution of new initiatives are key watchpoints for shareholders.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EW

No sentiment data available yet.

MCD
79% Buy21% Sell
Avg holding period · 164 Days

Top news

Latest headlines on both assets

About Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.

Read more on EW →

About McDonald's Corp

McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.

Read more on MCD →